Clinical Trial Update: Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating trabectedin for advanced uterine and ovarian carcinosarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinosarcoma of the Ovary
• Carcinosarcoma of the Uterus

Drugs mentioned

• Trabectedin (trabectedin)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Carcinosarcoma, Ovarian, Carcinosarcomas Uterine | Phase 2 | Status: COMPLETED